Evaluating the modern field reimbursement and access program: key considerations

By Xcenda |

How do pharmaceutical manufacturers create a field reimbursement and access program that addresses the challenges patients and providers face today?


Engaging providers is more challenging than ever amid a changing healthcare landscape and the continuing COVID-19 pandemic

Drug launches, provider education, payer requirements, and patient access create a complex web of compliance and relationship management issues. Field reimbursement and access programs serve as a clarifying bridge between providers and manufacturers, helping providers understand how to address any challenges that emerge. In the current environment, these programs are even more essential.